RPH-075
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RPH-075, covering 2024-03-20 to 2024-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma [Phase 3]